Home ›
Trademark Categories ›
Pharmaceuticals ›
2016 ›
SE ›
SELGILTA
Trademark search for:
SELGILTA
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2016-10-14 — Application filed
2017-01-05 — Sn assigned for sect 66a appl from ib
2017-01-10 — Application filed
2017-01-14 — Application filed
2017-01-25 — Assigned to examiner
2017-01-30 — Approved for pub - principal register
2017-02-22 — Notice of publication
2017-02-22 — Notification of possible opposition sent to ib
2017-02-22 — Notice of start of opposition period created, to be sent to ib
2017-03-11 — Notification processed by ib
2017-03-14 — Published for opposition
2017-05-30 — Registered-principal register
2017-06-29 — Grant of protection created, to be sent to ib
2017-07-06 — Final disposition recorded
2017-07-06 — Final disposition recorded
2017-07-28 — Notification processed by ib
2021-08-06 — New representative at ib received
2022-06-03 — Attorney/dom.rep.revoked and/or appointed
2022-06-03 — Teas change of domestic representatives address
2022-06-03 — Teas change of owner address received
2022-06-03 — Teas change of correspondence received
2022-06-03 — Applicant/correspondence changes (non-responsive) entered
2022-06-03 — Teas revoke/app/change addr of atty/dom rep received
2022-06-25 — New representative at ib received
2023-12-15 — Cancelled section 71
2023-12-15 — Final status recorded
2024-08-16 — Total invalidation of reg ext protection created
2024-08-28 — Total invalidation of reg ext protection sent to ib
2024-08-28 — Invalidation processed
2024-09-14 — Total invalidation processed by the ib
Owner Information
Astellas Pharma Inc.
JP
Astellas Pharma Inc.
JP
Astellas Pharma Inc.
JP
Correspondent
Christian S. Morgan Baker & McKenzie LLP 300 E. Randolph Street Suite 5000 Chicago, IL 60601
Filing Details
Filing Date:
2016-10-14
Status Date:
2023-12-15
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.